BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 11002419)

  • 21. Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway: importance for the rescue of neuroectodermic cells.
    Mograbi B; Bocciardi R; Bourget I; Busca R; Rochet N; Farahi-Far D; Juhel T; Rossi B
    J Biol Chem; 2001 Nov; 276(48):45307-19. PubMed ID: 11535584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells.
    Trupp M; Scott R; Whittemore SR; Ibáñez CF
    J Biol Chem; 1999 Jul; 274(30):20885-94. PubMed ID: 10409632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade.
    Uehara T; Tokumitsu Y; Nomura Y
    Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GDNF triggers a novel ret-independent Src kinase family-coupled signaling via a GPI-linked GDNF receptor alpha1.
    Poteryaev D; Titievsky A; Sun YF; Thomas-Crusells J; Lindahl M; Billaud M; Arumäe U; Saarma M
    FEBS Lett; 1999 Dec; 463(1-2):63-6. PubMed ID: 10601639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
    Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
    J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.
    De Vita G; Melillo RM; Carlomagno F; Visconti R; Castellone MD; Bellacosa A; Billaud M; Fusco A; Tsichlis PN; Santoro M
    Cancer Res; 2000 Jul; 60(14):3727-31. PubMed ID: 10919641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.
    Schlaepfer DD; Jones KC; Hunter T
    Mol Cell Biol; 1998 May; 18(5):2571-85. PubMed ID: 9566877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shc and Enigma are both required for mitogenic signaling by Ret/ptc2.
    Durick K; Gill GN; Taylor SS
    Mol Cell Biol; 1998 Apr; 18(4):2298-308. PubMed ID: 9528800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons.
    Pong K; Xu RY; Baron WF; Louis JC; Beck KD
    J Neurochem; 1998 Nov; 71(5):1912-9. PubMed ID: 9798915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase.
    Fukuda T; Kiuchi K; Takahashi M
    J Biol Chem; 2002 May; 277(21):19114-21. PubMed ID: 11886862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
    Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
    J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinase B activation and lamellipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras.
    van Weering DH; de Rooij J; Marte B; Downward J; Bos JL; Burgering BM
    Mol Cell Biol; 1998 Apr; 18(4):1802-11. PubMed ID: 9528752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Gab1 protein is a docking site for multiple proteins involved in signaling by the B cell antigen receptor.
    Ingham RJ; Holgado-Madruga M; Siu C; Wong AJ; Gold MR
    J Biol Chem; 1998 Nov; 273(46):30630-7. PubMed ID: 9804835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B; Cheng HL; Margolis B; Feldman EL
    J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
    Vacca F; Bagnato A; Catt KJ; Tecce R
    Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
    Kim B; Leventhal PS; White MF; Feldman EL
    Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of Vav and Ras through the nerve growth factor and B cell receptors by different kinases.
    Melamed I; Patel H; Brodie C; Gelfand EW
    Cell Immunol; 1999 Feb; 191(2):83-9. PubMed ID: 9973529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret.
    Melillo RM; Carlomagno F; De Vita G; Formisano P; Vecchio G; Fusco A; Billaud M; Santoro M
    Oncogene; 2001 Jan; 20(2):209-18. PubMed ID: 11313948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
    Geneste O; Bidaud C; De Vita G; Hofstra RM; Tartare-Deckert S; Buys CH; Lenoir GM; Santoro M; Billaud M
    Hum Mol Genet; 1999 Oct; 8(11):1989-99. PubMed ID: 10484767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.